Integral Ad Science (NASDAQ:IAS - Get Free Report)'s stock had its "hold" rating reiterated by equities research analysts at Benchmark in a research report issued on Thursday,Benzinga reports.
Several other equities analysts have also issued reports on the stock. Oppenheimer cut their price target on shares of Integral Ad Science from $20.00 to $18.00 and set an "outperform" rating on the stock in a report on Wednesday. Craig Hallum dropped their target price on Integral Ad Science from $18.00 to $16.00 and set a "buy" rating on the stock in a research note on Wednesday. Truist Financial decreased their price target on Integral Ad Science from $18.00 to $16.00 and set a "buy" rating for the company in a research note on Wednesday. Piper Sandler dropped their price target on Integral Ad Science from $18.00 to $16.00 and set an "overweight" rating on the stock in a research note on Wednesday. Finally, Morgan Stanley increased their price objective on shares of Integral Ad Science from $12.00 to $13.00 and gave the company an "equal weight" rating in a research report on Tuesday, July 23rd. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $15.70.
Check Out Our Latest Analysis on Integral Ad Science
Integral Ad Science Stock Down 0.2 %
Shares of NASDAQ:IAS traded down $0.02 on Thursday, reaching $10.77. The company had a trading volume of 1,018,965 shares, compared to its average volume of 1,390,188. The firm has a market capitalization of $1.74 billion, a PE ratio of 53.45, a PEG ratio of 1.90 and a beta of 1.52. The company has a current ratio of 3.76, a quick ratio of 3.76 and a debt-to-equity ratio of 0.10. Integral Ad Science has a 52-week low of $7.98 and a 52-week high of $17.53. The firm's 50 day simple moving average is $11.12 and its 200-day simple moving average is $10.46.
Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its earnings results on Tuesday, November 12th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.02. Integral Ad Science had a return on equity of 3.52% and a net margin of 6.39%. The company had revenue of $133.50 million for the quarter, compared to analyst estimates of $138.06 million. During the same quarter in the previous year, the firm earned ($0.09) earnings per share. The firm's quarterly revenue was up 11.0% compared to the same quarter last year. As a group, analysts expect that Integral Ad Science will post 0.23 earnings per share for the current fiscal year.
Insider Buying and Selling at Integral Ad Science
In other news, CFO Tania Secor sold 5,240 shares of the firm's stock in a transaction dated Monday, October 7th. The shares were sold at an average price of $10.11, for a total value of $52,976.40. Following the transaction, the chief financial officer now directly owns 248,223 shares of the company's stock, valued at approximately $2,509,534.53. This trade represents a 2.07 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Lisa Utzschneider sold 10,481 shares of the company's stock in a transaction dated Monday, October 7th. The shares were sold at an average price of $10.11, for a total transaction of $105,962.91. Following the sale, the chief executive officer now directly owns 239,709 shares of the company's stock, valued at approximately $2,423,457.99. This represents a 4.19 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 23,006 shares of company stock valued at $240,296 over the last ninety days. Corporate insiders own 2.00% of the company's stock.
Institutional Investors Weigh In On Integral Ad Science
Hedge funds and other institutional investors have recently made changes to their positions in the stock. PDT Partners LLC lifted its holdings in Integral Ad Science by 9.9% in the third quarter. PDT Partners LLC now owns 283,213 shares of the company's stock valued at $3,062,000 after acquiring an additional 25,546 shares during the last quarter. PEAK6 Investments LLC acquired a new position in shares of Integral Ad Science in the 3rd quarter valued at $213,000. Quantbot Technologies LP purchased a new position in shares of Integral Ad Science during the 3rd quarter worth $106,000. Crestwood Capital Management L.P. increased its position in shares of Integral Ad Science by 0.3% during the 3rd quarter. Crestwood Capital Management L.P. now owns 650,738 shares of the company's stock worth $7,034,000 after purchasing an additional 1,941 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in Integral Ad Science in the 3rd quarter valued at about $180,000. Institutional investors and hedge funds own 95.78% of the company's stock.
Integral Ad Science Company Profile
(
Get Free Report)
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
See Also
Before you consider Integral Ad Science, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.
While Integral Ad Science currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for November 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.